GSXCX
Price
$28.87
Change
+$0.36 (+1.26%)
Updated
Dec 3 closing price
Net Assets
354.85M
VISGX
Price
$85.38
Change
+$0.83 (+0.98%)
Updated
Dec 3 closing price
Net Assets
39.74B
Interact to see
Advertisement

GSXCX vs VISGX

Header iconGSXCX vs VISGX Comparison
Open Charts GSXCX vs VISGXBanner chart's image
abrdn US Small Cap Equity C
Price$28.87
Change+$0.36 (+1.26%)
VolumeN/A
Net Assets354.85M
Vanguard Small Cap Growth Index I
Price$85.38
Change+$0.83 (+0.98%)
VolumeN/A
Net Assets39.74B
GSXCX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
GSXCX vs. VISGX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSXCX is a Buy and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 39.7B vs. GSXCX (355M). VISGX pays higher dividends than GSXCX: VISGX (0.43) vs GSXCX (0.00). GSXCX was incepted earlier than VISGX: GSXCX (25 years) vs VISGX (28 years). GSXCX (2.19) is less costly to investors than VISGX (0.19). GSXCX is a more actively managed with annual turnover of: 47.00 vs. VISGX (21.00). GSXCX has a lower initial minimum investment than VISGX: GSXCX (1000) vs VISGX (3000). GSXCX annual gain was more profitable for investors over the last year : 4.07 vs. VISGX (0.90). VISGX return over 5 years is better than : 20.84 vs. GSXCX (-9.13).
GSXCXVISGXGSXCX / VISGX
Total Expense Ratio1.950.191,026%
Annual Report Gross Expense Ratio2.190.191,153%
Fund Existence25 years28 years-
Gain YTD11.1248.543130%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets355M39.7B1%
Annual Yield % from dividends0.000.43-
Returns for 1 year4.070.90454%
Returns for 3 years22.0241.1853%
Returns for 5 years-9.1320.84-44%
Returns for 10 years19.05147.5113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX53.401.07
+2.04%
Rydex Biotechnology C
JDINX56.570.26
+0.46%
Janus Henderson Overseas N
RAEBX46.480.11
+0.24%
American Funds AMCAP R2E
GSURX69.620.04
+0.06%
Goldman Sachs US Equity Insights R
MUOCX31.900.01
+0.03%
Morgan Stanley Instl US Core C